| P50 | author | Maria A Croyle | Q90384070 |
| P2093 | author name string | Joseph D Dekker | |
| | Piyanuch Wonganan | |
| | Michael P Boquet | |
| P2860 | cites work | A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 |
| | Control of adenovirus acute respiratory disease in U.S. Army trainees | Q34040015 |
| | Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide | Q34697474 |
| | Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications | Q34717992 |
| | Immune responses to gene therapy vectors: influence on vector function and effector mechanisms | Q35904408 |
| | Production and formulation of adenovirus vectors. | Q36433876 |
| | Current advances and future challenges in Adenoviral vector biology and targeting | Q36463004 |
| | Influence of mode of intravenous administration and blood sample collection on rat pharmacokinetic data | Q36610581 |
| | Antipyrine and acetaminophen kinetics in the rat: comparison of data based on blood samples from the cut tail and a cannulated femoral artery | Q36650558 |
| | Oncolytic viruses in cancer therapy | Q36769180 |
| | The physicochemistry of endotoxins in relation to bioactivity | Q36798832 |
| | Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. | Q36811133 |
| | The influence of blood on in vivo adenovirus bio-distribution and transduction. | Q36823688 |
| | Innate immune response induced by gene delivery vectors | Q36886619 |
| | Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection | Q36932523 |
| | Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects. | Q36990088 |
| | How not to be seen: immune-evasion strategies in gene therapy. | Q37018636 |
| | The current state of serum biomarkers of hepatotoxicity. | Q37091307 |
| | Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded | Q37191007 |
| | Conformational stability of globular proteins | Q37809418 |
| | Adenovirus aggregation and preservation in extracellular environment | Q39242010 |
| | Methods for Vascular Access and Collection of Body Fluids from the Laboratory Rat | Q40151522 |
| | Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. | Q40502063 |
| | Fever onset is linked to the appearance of lipopolysaccharide in the liver | Q40538129 |
| | A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles | Q40729837 |
| | Toward understanding insulin fibrillation | Q41466059 |
| | Testosterone metabolism by cytochrome P-450 isozymes RLM3 and RLM5 and by microsomes. Metabolite identification. | Q42253192 |
| | Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types | Q43494742 |
| | The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition | Q43855708 |
| | Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes | Q44154015 |
| | Effect of cannulation surgery and restraint stress on the plasma corticosterone concentration in the rat: application of an improved corticosterone HPLC assay | Q44560208 |
| | Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver | Q45073993 |
| | Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450. | Q45117126 |
| | Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion | Q45158832 |
| | PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver | Q45855754 |
| | Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease | Q45872936 |
| | Fiber-modified adenoviruses for targeted gene therapy | Q45877452 |
| | Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy | Q46577749 |
| | Impact of transgene expression on drug metabolism following systemic adenoviral vector administration | Q46969600 |
| | Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats | Q47353872 |
| | Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat. | Q48446866 |
| | Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs. | Q52580296 |
| | Safety of intravenous immunoglobulin. | Q53786118 |
| | Methodology of fever research: why are polyphasic fevers often thought to be biphasic? | Q53948431 |
| | Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver | Q58483896 |
| | Renal pathophysiology after systemic administration of recombinant adenovirus: changes in renal cytochromes P450 based on vector dose | Q64377434 |
| | Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene | Q64379227 |
| | The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 | Q64383973 |
| | Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat | Q67657482 |
| | Effect of sampling site and collection method on variations in baseline clinical pathology parameters in Fischer-344 rats. II. Clinical hematology | Q69721482 |
| | Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter | Q71074179 |
| | THE TAIL OF THE RAT, IN TEMPERATURE REGULATION AND ACCLIMATIZATION | Q78495358 |
| | Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer | Q80546801 |
| P433 | issue | 3 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 222-232 | |
| P577 | publication date | 2008-08-03 | |
| P1433 | published in | Journal of Pharmacological and Toxicological Methods | Q15724529 |
| P1476 | title | Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism | |
| P478 | volume | 58 | |